Cytomx Therapeutics (CTMX)'s 30-day implied volatility (IV30) was 116.5% at the close on November 6, 2026, up from 83.3% the day before, against a 52-week range of 48.5% to 336.0%. Its 20-day historical volatility was 69.3%.
Data as of November 6, 2026.